These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18060329)

  • 1. Membranous dysmenorrhea: a case series.
    Omar HA; Smith SJ
    ScientificWorldJournal; 2007 Nov; 7():1900-3. PubMed ID: 18060329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis.
    Vercellini P; De Giorgi O; Oldani S; Cortesi I; Panazza S; Crosignani PG
    Am J Obstet Gynecol; 1996 Aug; 175(2):396-401. PubMed ID: 8765259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic fatigue syndrome: a hormonal origin? A rare case of dysmenorrhea membranacea.
    Veldman J; Van Houdenhove B; Verguts J
    Arch Gynecol Obstet; 2009 May; 279(5):717-20. PubMed ID: 18787800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method.
    Bonny AE; Ziegler J; Harvey R; Debanne SM; Secic M; Cromer BA
    Arch Pediatr Adolesc Med; 2006 Jan; 160(1):40-5. PubMed ID: 16389209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate induced amenorrhea.
    Piya-Anant M; Koetsawang S; Patrasupapong N; Dinchuen P; d'Arcangues C; Piaggio G; Pinol A
    Contraception; 1998 Jan; 57(1):23-8. PubMed ID: 9554247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroidal contraceptives and bone fractures in women: evidence from observational studies.
    Lopez LM; Chen M; Mullins S; Curtis KM; Helmerhorst FM
    Cochrane Database Syst Rev; 2012 Aug; (8):CD009849. PubMed ID: 22895991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decidual cast after discontinuation of oral contraceptives use in a young girl.
    Sen Y; Cimbek EA; Uğraş NS
    J Pediatr Adolesc Gynecol; 2013 Dec; 26(6):e127-9. PubMed ID: 23870823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.
    Kaunitz AM
    J Reprod Med; 1996 May; 41(5 Suppl):419-27. PubMed ID: 8725705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study.
    Cromer BA; Bonny AE; Stager M; Lazebnik R; Rome E; Ziegler J; Camlin-Shingler K; Secic M
    Fertil Steril; 2008 Dec; 90(6):2060-7. PubMed ID: 18222431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
    Rosenfield A; Maine D; Rochat R; Shelton J; Hatcher RA
    JAMA; 1983 Jun; 249(21):2922-8. PubMed ID: 6221125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness.
    Whiteman MK; Jeng G; Samarina A; Akatova N; Martirosyan M; Kissin DM; Curtis KM; Marchbanks PA; Hillis SD; Mandel MG; Jamieson DJ
    Contraception; 2016 Jan; 93(1):17-24. PubMed ID: 26197261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
    Cundy T; Evans M; Roberts H; Wattie D; Ames R; Reid IR
    BMJ; 1991 Jul; 303(6793):13-6. PubMed ID: 1830502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls.
    Cromer BA; Stager M; Bonny A; Lazebnik R; Rome E; Ziegler J; Debanne SM
    J Adolesc Health; 2004 Dec; 35(6):434-41. PubMed ID: 15581522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate monthly combination contraception to facilitate initiation of the depot medroxyprogesterone acetate contraceptive injection.
    Morroni C; Grams M; Tiezzi L; Westhoff C
    Contraception; 2004 Jul; 70(1):19-23. PubMed ID: 15208048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depot medroxyprogesterone acetate contraception in women with medical problems.
    Frederiksen MC
    J Reprod Med; 1996 May; 41(5 Suppl):414-8. PubMed ID: 8725704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections.
    Harel Z; Johnson CC; Gold MA; Cromer B; Peterson E; Burkman R; Stager M; Brown R; Bruner A; Coupey S; Hertweck P; Bone H; Wolter K; Nelson A; Marshall S; Bachrach LK
    Contraception; 2010 Apr; 81(4):281-91. PubMed ID: 20227543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight change in adolescents who used hormonal contraception.
    Risser WL; Gefter LR; Barratt MS; Risser JM
    J Adolesc Health; 1999 Jun; 24(6):433-6. PubMed ID: 10401972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial Cast Expulsion: A Rare Cause of Pelvic Pain Case Report and Review of the Literature.
    Parkes P; Trainor JL; Raval M; Dhar CP
    J Adolesc Health; 2021 May; 68(5):1017-1019. PubMed ID: 33041203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting hormonal contraceptives for women.
    Garza-Flores J; Hall PE; Perez-Palacios G
    J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.